STOCK TITAN

Electromedical Technologies Unveils Groundbreaking Details About the WellnessPro Infinity and Announces Production Timeline

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Positive)
Tags

Electromedical Technologies (OTC PINK:EMED) has announced key updates for its WellnessPro Infinity pain management device, scheduled for production in early 2025. The device features 11 circuit boards spanning one-square-foot and contains 1,454 individual components, including advanced microcontrollers, precision resistors, capacitors, signal amplifiers, power management systems, and user interface modules.

Production is set to begin in the third week of 2025, following factory evaluations. The company has faced challenges including global supply chain disruptions and European manufacturing standards. EMED confirms it will honor all pre-sale pricing for existing orders, despite planned price adjustments in 2025.

Electromedical Technologies (OTC PINK:EMED) ha annunciato aggiornamenti importanti per il suo dispositivo per la gestione del dolore WellnessPro Infinity, previsto per la produzione all'inizio del 2025. Il dispositivo è dotato di 11 circuiti stampati che coprono un'area di un piede quadrato e include 1.454 componenti individuali, tra cui microcontrollori avanzati, resistori di precisione, condensatori, amplificatori di segnale, sistemi di gestione dell'energia e moduli per l'interfaccia utente.

La produzione è prevista per iniziare nella terza settimana del 2025, dopo le valutazioni della fabbrica. L'azienda ha dovuto affrontare sfide come le interruzioni nella catena di approvvigionamento globale e gli standard di produzione europei. EMED conferma che onorerà tutti i prezzi di presale per gli ordini esistenti, nonostante gli aggiustamenti di prezzo previsti per il 2025.

Electromedical Technologies (OTC PINK:EMED) ha anunciado actualizaciones clave para su dispositivo de manejo del dolor WellnessPro Infinity, programado para producción a principios de 2025. El dispositivo cuenta con 11 placas de circuito que abarcan un pie cuadrado y contiene 1,454 componentes individuales, incluyendo microcontroladores avanzados, resistencias de precisión, capacitores, amplificadores de señal, sistemas de gestión de energía y módulos de interfaz de usuario.

La producción comenzará en la tercera semana de 2025, después de las evaluaciones de la fábrica. La empresa ha enfrentado desafíos como las interrupciones en la cadena de suministro global y los estándares de fabricación europeos. EMED confirma que honrará todos los precios de pre-venta para los pedidos existentes, a pesar de los ajustes de precios previstos para 2025.

Electromedical Technologies (OTC PINK:EMED)는 2025년 초 생산 예정인 통증 관리 장치 WellnessPro Infinity에 대한 주요 업데이트를 발표했습니다. 이 장치는 한 평방피트를 차지하는 11개의 회로 기판을 갖추고 있으며, 1,454개의 개별 부품이 포함되어 있습니다. 여기에는 고급 마이크로컨트롤러, 정밀 저항기, 커패시터, 신호 증폭기, 전원 관리 시스템 및 사용자 인터페이스 모듈이 포함됩니다.

생산은 공장 평가 후 2025년 3주 차에 시작될 예정입니다. 이 회사는 글로벌 공급망 중단 및 유럽 제조 기준 등 여러 가지 문제에 직면했습니다. EMED는 2025년에 예정된 가격 조정에도 불구하고 기존 주문에 대해 모든 사전 판매 가격을 유지할 것이라고 확인했습니다.

Electromedical Technologies (OTC PINK:EMED) a annoncé des mises à jour clés pour son dispositif de gestion de la douleur WellnessPro Infinity, dont la production est prévue pour début 2025. Le dispositif comporte 11 cartes de circuits occupant un pied carré et contient 1 454 composants individuels, notamment des microcontrôleurs avancés, des résistances de précision, des condensateurs, des amplificateurs de signal, des systèmes de gestion de l'énergie et des modules d'interface utilisateur.

La production doit commencer lors de la troisième semaine de 2025, après des évaluations de l'usine. L'entreprise a été confrontée à des défis, notamment des perturbations de la chaîne d'approvisionnement mondiale et des normes de fabrication européennes. EMED confirme qu'il honorera tous les prix de pré-vente pour les commandes existantes, malgré les ajustements de prix prévus pour 2025.

Electromedical Technologies (OTC PINK:EMED) hat wichtige Updates für sein WellnessPro Infinity-Schmerzmanagementgerät angekündigt, das Anfang 2025 in Produktion gehen soll. Das Gerät umfasst 11 Leiterplatten, die einen Quadratfuß abdecken, und enthält 1.454 einzelne Komponenten, darunter fortschrittliche Mikrocontroller, Präzisionswiderstände, Kondensatoren, Signalverstärker, Energiemanagementsysteme und Benutzeroberflächenmodule.

Die Produktion soll in der dritten Woche des Jahres 2025 beginnen, nach Evaluierungen der Fabrik. Das Unternehmen sieht sich Herausforderungen gegenüber, darunter Störungen in der globalen Lieferkette und europäische Produktionsstandards. EMED bestätigt, dass alle Vorverkaufspreise für bestehende Bestellungen eingehalten werden, trotz geplanter Preisänderungen im Jahr 2025.

Positive
  • Advanced technology integration with 11 circuit boards and 1,454 components
  • Production timeline confirmed for Q1 2025
  • Commitment to honor pre-sale pricing despite planned 2025 price increases
Negative
  • Production delayed until Q1 2025 due to supply chain issues
  • Challenges in sourcing critical components like microcontrollers
  • Facing complications with European manufacturing standards compliance

Electromedical Technologies is excited to share key updates on the WellnessPro Infinity, a revolutionary device redefining the standards of pain management and wellness technology.

SCOTTSDALE, ARIZONA / ACCESSWIRE / December 11, 2024 / Electromedical Technologies, Inc. (OTC PINK:EMED) - Electromedical Technologies is excited to share key updates on the WellnessPro Infinity, a revolutionary device redefining the standards of pain management and wellness technology. With production set to ramp up in early 2025, the WellnessPro Infinity is poised to deliver unparalleled precision and performance, setting a new benchmark in its class.

A Journey of Innovation

At the heart of the WellnessPro Infinity is an unprecedented design that incorporates 11 intricately engineered circuit boards covering nearly one-square-foot and 1,454 individual components, all housed within a sleek looking device.

Each circuit board serves a specific function, working in perfect synchronization to ensure precision and efficiency. These boards include cutting-edge:

  • Microcontrollers: Advanced processors regulate input and output signals, ensuring reliable and consistent operation. These components are highly sought after in industries like automotive and military for their durability and precision.

  • Precision Resistors and Capacitors: These components ensure signal accuracy and stability, providing the consistent therapeutic effects the WellnessPro Infinity is known for.

  • Signal Amplifiers: Amplify low-level electrical signals to deliver varying intensities for customized treatment.

  • Power Management Systems: Ensure optimal energy usage, protect the device from surges, and extend the device's operational lifespan.

  • User Interface Modules: Enable intuitive control, allowing users to customize treatment settings with ease.

This intricate assembly highlights the company's dedication to innovation, bringing together advanced engineering and cutting-edge technology to create a device that stands apart in the marketplace.

Overcoming Challenges Together

The road to production has been both complex and rewarding. Global supply chain disruptions and rigorous European manufacturing standards posed significant challenges. Additionally, sourcing high-demand components, such as microcontrollers often reserved for critical industries like military and automotive, added to the production intricacy.

"We deeply appreciate the patience of our customers and partners as we've worked to overcome these challenges," said Matthew Wolfson, Chief Executive Officer of Electromedical Technologies. "The WellnessPro Infinity will deliver on its promise to revolutionize pain management, making it well worth the wait."

Looking Ahead

Production is scheduled to ramp up in the third week of 2025, with rigorous factory evaluations underway to ensure all processes meet the company's high standards. Electromedical Technologies will provide detailed shipping timelines once evaluations are complete.

For customers who pre-ordered the device, Electromedical Technologies reaffirms its commitment to honor all pre-sale pricing, even as market prices are set to adjust in 2025.

Thank You for Believing in Us

The WellnessPro Infinity is not just a device-it's a testament to innovation, resilience, and a shared vision for improving lives through technology.

"By choosing the WellnessPro Infinity, you've joined us on a journey to bring cutting-edge technology to life," Mr. Wolfson added. "We're grateful for your belief in this revolutionary product and excited about the transformative impact it will have."

About Electromedical Technologies

Electromedical Technologies is a leader in the development of bioelectronic devices that improve health and wellness. Dedicated to innovation and excellence, the company's flagship products provide effective pain relief and enhance quality of life through advanced technology.

For more information, visit www.electromedtech.com.

Corporate Contact:
Electromedical Technologies, Inc. Tel: 1.888.880.7888
Email: ir@electromedtech.com
https://electromedtech.com

Contact Information

Cristina Clubb
Electromedical Technologies, Inc.
ir@electromedtech.com

.

SOURCE: Electromedical Technologies, Inc.



View the original press release on accesswire.com

FAQ

When will EMED start production of the WellnessPro Infinity device?

Production of the WellnessPro Infinity is scheduled to begin in the third week of 2025.

What are the key technical specifications of EMED's WellnessPro Infinity?

The WellnessPro Infinity features 11 circuit boards covering one-square-foot, containing 1,454 components including microcontrollers, precision resistors, capacitors, signal amplifiers, power management systems, and user interface modules.

Will EMED honor pre-sale prices for WellnessPro Infinity orders?

Yes, Electromedical Technologies has confirmed it will honor all pre-sale pricing for existing orders, despite planned price adjustments in 2025.

What challenges is EMED facing with WellnessPro Infinity production?

EMED is facing challenges including global supply chain disruptions, European manufacturing standards compliance, and difficulty sourcing high-demand components like microcontrollers.

ELECTROMEDICAL TECH INC

OTC:EMED

EMED Rankings

EMED Latest News

EMED Stock Data

342.02k
839.13M
5.96%
Medical Devices
Healthcare
Link
United States of America
Scottsdale